Studies have shown that two, instead of three doses, of the HPV vaccine may be enough to prevent the virus

The HPV Cancer Vaccine: Two Doses May Be Enough

Studies have shown that two, instead of three doses, of the HPV vaccine may be enough to prevent the virus On Monday the 25th of August, the 29th International Papillomavirus Conference came to a close in Seattle, USA. Amongst the most hotly debated topics at the conference was lowering the number of doses of the vaccine to boost adherence rates. …

Polio Strain Resistant to Vaccine was Responsible for 2010 Congo Outbreak

A vaccine resistant mutation of the poliovirus was the cause of the major 2010 polio outbreak in DR Congo Research published in the scientific journal ‘Proceedings of the National Academy of Sciences‘ has shown that a mutated strain of the poliovirus was responsible for a 2010 outbreak in the Democratic Republic of Congo, which claimed 209 lives. It was initially …

New Vaccine Provides Greater Protection than BCG Against Both Tuberculosis and Leprosy

Research headed by UCLA has found that a variation of the BCG vaccine offers stronger protection against the diseases Both tuberculosis and leprosy often occur together, and leprosy usually only occurs in places where tuberculosis occurs. Most infants are vaccinated against the two diseases with the Bacille Calmette-Guerin vaccination, which has been used for over a century now. However this …

Exclusive vaccine delivery interview with Dr Chantal Pichon, University of Orleans and CNRS

The 15th World Vaccine Congress on 13 – 15 October in Brussels is just a few weeks away and I recently sat down with one of our key speakers, Dr Chantal Pichon (Professor, University of Orleans and CNRS Center for Molecular Biophysics) for a short interview. Dr Pichon will be discussing her research in Histidylated-based nanoparticles for mRNA vaccines delivery. …

Chikungunya vaccine candidate causes successful development of antibodies against the virus

Chikungunya Vaccine Candidate Passes Phase I Clinical Trials

Chikungunya vaccine candidate causes successful development of antibodies against the virus Chikungunya, a mosquito borne virus, has recently been responsible for outbreaks in the Caribbean and the Pacific. Although the disease is not usually fatal, it causes similar symptoms to a bad flu: muscle aches, malaise and headaches. However, one of the unique aspects of the virus is that it …

Pfizer's Pneumococcal Vaccine Could See a Boost in Sales After the CDC's Recommendation for Use in Older Adults

Pfizer’s Prevnar 13 Could See a $2 Billion Boost in Sales

Pfizer’s Pneumococcal Vaccine Could See a Boost in Sales After the CDC’s Recommendation for Use in Older Adults On Wednesday, Pfizer announced that the CDC’s Advisory Committee on Immunisation Practices (ACIP) has decided to recommend and promote the Prevnar 13 pneumococcal vaccine for use in adults aged 65 and up. The vaccine protects against pneumococcal diseases including pneumonia, which can …

Researchers at Stanford Retract Narcolepsy Study Linked to GSK’s Swine Flu Vaccine

Stanford University researchers have retracted a major study that sought to explain why some abruptly fell asleep after receiving Pandemrix vaccine Researchers at the University of Stanford School of Medicine have retracted a study they published last year which endeavoured to explain why some people were falling asleep after receiving a GSK Swine Flu vaccine called Pandemrix. The researchers behind …

What impact will the Ebola outbreak have on vaccine development for other neglected tropical diseases?

The 2014 Ebola outbreak in West Africa has devastated communities, leaving over 1000 dead according to WHO. Although arguably largely unreported in mainstream media until it started spreading outside of Africa, there is now lots of action in the Ebola space from companies throughout the world. It is unfortunate that it has taken this long for Ebola to get so …

NewLink Genetics Claims Most Advanced Ebola Vaccine Candidate

NewLink Genetics Claims Most Advanced Ebola Vaccine Candidate

American Pharmaceutical Company Could Soon Be Carrying Out Human Trials For Its Ebola Vaccine Candidate NewLink Genetics, an American pharmaceutical company based in Ames, Iowa will be continuing work on an Ebola vaccine candidate that has already been proven to be effective in primates. Although the company usually focuses on cancer research, it announced that the the United States Defense …